WallStreetZenWallStreetZen

NYSEMKT: PLX
Protalix Biotherapeutics Inc Stock Ownership - Who owns Protalix Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Protalix Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dror BashanPRESIDENT AND CEO2025-12-1956,000$1.81
$101.36kBuy
Amos BarshalevDirector2025-11-18168$1.87
$314.16Sell
Aharon SchwartzDirector2025-06-10129,000$1.60
$205.88kBuy

1 of 1

PLX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PLX insiders and whales buy or sell their stock.

PLX Shareholders

What type of owners hold Protalix Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Biocell Ltd37.78%30,442,586$67.28MInsider
Phillip Md Et Al Frost22.57%18,184,566$40.19MInsider
Zeev Bronfeld20.64%16,628,800$36.75MInsider
Eyal Sheratzki17.95%14,466,319$31.97MInsider
Camber Capital Management LP13.37%10,775,000$23.81MInsider
Sharon Toussiacohen8.14%6,556,381$14.49MInsider
Marathon Investments Ltd8.14%6,556,381$14.49MInsider
Amos Barshalev7.69%6,193,546$13.69MInsider
Technorov Holdings 1993 Ltd7.68%6,186,046$13.67MInsider
Eli Hurvitz6.64%5,353,923$11.83MInsider

1 of 3

PLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PLX9.84%90.16%Net Buying
CNTN14.25%9.84%Net Buying
TNXP19.57%80.43%Net BuyingNet Buying
PRQR35.27%1.57%
CRBU38.43%8.91%Net SellingNet Selling
View Top Biotech Stocks

Protalix Biotherapeutics Stock Ownership FAQ

Who owns Protalix Biotherapeutics?

Protalix Biotherapeutics (NYSEMKT: PLX) is owned by 18.50% institutional shareholders, 169.55% Protalix Biotherapeutics insiders, and 0.00% retail investors. Biocell Ltd is the largest individual Protalix Biotherapeutics shareholder, owning 30.44M shares representing 37.78% of the company. Biocell Ltd's Protalix Biotherapeutics shares are currently valued at $66.67M.

If you're new to stock investing, here's how to buy Protalix Biotherapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.